Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Disease crawled date : 2021 - 11 - 16 save search
Heart Disease Therapies Pack a Punch with Promising Study Results
Published: 2021-11-16 (Crawled : 17:00) - biospace.com/
MESO | $5.97 7.96% 7.37% 630K
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
disease heart disease heart results therapy
Quanterix’ Simoa® Technology Powers Advances in Alzheimer’s Disease Research Presented at 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Published: 2021-11-16 (Crawled : 15:30) - biospace.com/
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
QTRX | $16.085 -1.32% -1.34% 410K
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: -1.52%
disease alzheimer clinical trials trials technology research trial conference alzheimer’s alzheimer's disease alzheimer's
Maryland Physicians Care (MPC) Selects NantHealth’s Eviti Connect to Validate Treatment For Members with Autoimmune Diseases
Published: 2021-11-16 (Crawled : 14:00) - nanthealth.com
NH | $1.35 -46.64% -1.48% 0
|
Technology Services
|
| O: 0.65%
H: 0.0%
C: -1.94%
disease treatment
Vaxart Announces Publication of Complete Data from Preclinical COVID-19 Oral Vaccine Hamster Challenge Study in Journal of Infectious Diseases
Published: 2021-11-16 (Crawled : 13:30) - globenewswire.com
VXRT | News | $0.7422 -2.66% -2.74% 1.5M
|
Health Technology
|
| O: -3.34%
H: 0.0%
C: 0.0%
covid disease preclinical infectious disease vaccine pre-clinical
Cyclo Therapeutics Submits Investigational New Drug Application to U.S. FDA to Advance Trappsol® Cyclo™ in Phase 2 Study for Treatment of Alzheimer’s Disease
Published: 2021-11-16 (Crawled : 13:30) - biospace.com/
CYTH | $1.26 7.94% 33K
|
Professional, Scientific, and T...
|
| O: 4.33%
H: 7.65%
C: -4.8%
new drug disease alzheimer treatment fda phase 2 application drug alzheimer’s alzheimer's disease alzheimer's
Humacyte Presents Preclinical Results of Small-Diameter HAV™ for Use as a BTT Shunt in Pediatric Heart Disease at American Heart Association’s Scientific Sessions 2021
Published: 2021-11-16 (Crawled : 13:00) - biospace.com/
HUMA | $3.925 6.08% 5.73% 2.1M
|
Manufacturing
|
| O: 5.85%
H: 8.76%
C: 5.9%
disease preclinical heart disease heart results pre-clinical
Viz.ai Launches Two New AI-Powered Modules for Pulmonary Embolism and Aortic Disease
Published: 2021-11-16 (Crawled : 12:30) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -0.07%
H: 0.0%
C: 0.0%
disease
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.